Stock VTR VENTAS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ventas, Inc.

Equities

VTR

US92276F1003

Specialized REITs

Market Closed - Nyse
Other stock markets
 04:00:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
44 USD +1.48% Intraday chart for Ventas, Inc. +2.02% -11.72%
Apr. 24 Ventas, Inc. Closes Extended and Improved $2.75 Billion Unsecured Credit Facility CI
Mar. 18 Evercore ISI Upgrades Ventas to Outperform From In Line, Price Target is $50 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 21,522 18,369 20,406 18,007 20,041 17,721 - -
Enterprise Value (EV) 1 33,574 29,813 32,284 30,182 33,023 30,931 30,951 31,166
P/E ratio 49.4 x 41.9 x 393 x -375 x -498 x -34.1 x -56.2 x -83 x
Yield 5.49% 4.37% 3.52% 4% 3.61% 4.2% 4.38% 4.79%
Capitalization / Revenue 5.56 x 4.84 x 5.33 x 4.36 x 4.46 x 3.69 x 3.49 x 3.36 x
EV / Revenue 8.67 x 7.86 x 8.43 x 7.31 x 7.34 x 6.45 x 6.1 x 5.91 x
EV / EBITDA 17.2 x 16.1 x 19.5 x 17.3 x 18 x 16.3 x 15.1 x 14.3 x
EV / FCF 38.3 x - - - - 42.2 x 36.2 x 32.1 x
FCF Yield 2.61% - - - - 2.37% 2.76% 3.11%
Price to Book 2.02 x 1.8 x 1.88 x 1.77 x 2.13 x 2.11 x 2.78 x 3.36 x
Nbr of stocks (in thousands) 372,736 374,571 399,176 399,718 402,104 402,752 - -
Reference price 2 57.74 49.04 51.12 45.05 49.84 44.00 44.00 44.00
Announcement Date 2/20/20 2/18/21 2/17/22 2/9/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,873 3,795 3,828 4,129 4,498 4,797 5,072 5,278
EBITDA 1 1,955 1,856 1,656 1,744 1,834 1,897 2,053 2,184
EBIT 1 909.8 746.7 459 545.7 441.6 182.3 284.6 343.7
Operating Margin 23.49% 19.67% 11.99% 13.22% 9.82% 3.8% 5.61% 6.51%
Earnings before Tax (EBT) 1 359.4 344.7 61.39 -64.37 -50.51 -518.9 -407.2 -306
Net income 1 433 439.1 49.01 -47.45 -40.97 -534.4 -262 -334.7
Net margin 11.18% 11.57% 1.28% -1.15% -0.91% -11.14% -5.17% -6.34%
EPS 2 1.170 1.170 0.1300 -0.1200 -0.1000 -1.290 -0.7832 -0.5300
Free Cash Flow 1 877.1 - - - - 733.6 854.1 969.6
FCF margin 22.65% - - - - 15.29% 16.84% 18.37%
FCF Conversion (EBITDA) 44.86% - - - - 38.68% 41.6% 44.4%
FCF Conversion (Net income) 202.56% - - - - - - -
Dividend per Share 2 3.170 2.142 1.800 1.800 1.800 1.847 1.925 2.106
Announcement Date 2/20/20 2/18/21 2/17/22 2/9/23 2/14/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 976.1 1,022 1,018 1,023 1,037 1,051 1,077 1,106 1,150 1,164 1,171 1,190 1,210 1,226 1,236
EBITDA 1 408.2 405.3 431.2 416.4 438.4 441.4 432.2 459.8 469.9 472.1 452.1 473.5 481.2 487.9 497.1
EBIT 1 94.65 86.36 142.2 133.3 136.9 117.2 150.1 155.2 99.51 36.82 55.02 78.26 72.42 68.02 -
Operating Margin 9.7% 8.45% 13.97% 13.03% 13.2% 11.15% 13.93% 14.02% 8.65% 3.16% 4.7% 6.58% 5.98% 5.55% -
Earnings before Tax (EBT) 1 - - - - - - - - - - -138.3 -124.8 -128.8 -127 -121.1
Net income 1 60.68 -40.85 38.73 -42.42 1.256 -45.02 17.52 103.5 -71.12 -90.82 -148.7 -132.5 -126.1 -125.9 -90.8
Net margin 6.22% -4% 3.81% -4.15% 0.12% -4.28% 1.63% 9.35% -6.19% -7.8% -12.7% -11.14% -10.42% -10.28% -7.35%
EPS 2 0.1600 -0.1000 0.1000 -0.1100 - -0.1100 0.0400 0.2600 -0.1800 -0.2300 -0.3633 -0.3200 -0.2967 -0.2800 -0.1666
Dividend per Share 2 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4500 0.4529 0.4636 0.4668 0.4682 0.4838
Announcement Date 11/5/21 2/17/22 5/5/22 8/4/22 11/3/22 2/9/23 5/8/23 8/3/23 11/2/23 2/14/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 12,052 11,444 11,878 12,174 12,982 13,210 13,230 13,445
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 6.164 x 6.164 x 7.171 x 6.983 x 7.078 x 6.964 x 6.444 x 6.157 x
Free Cash Flow 1 877 - - - - 734 854 970
ROE (net income / shareholders' equity) 4.19% 4.26% 0.47% -0.45% -0.42% -5.71% -5.4% -5.1%
ROA (Net income/ Total Assets) 1.83% 1.81% 0.2% -0.19% -0.17% -2.2% -1.08% -0.59%
Assets 1 23,638 24,311 24,324 24,457 24,102 24,290 24,343 56,620
Book Value Per Share 2 28.50 27.20 27.20 25.40 23.40 20.90 15.80 13.10
Cash Flow per Share 2 3.890 3.850 2.660 2.780 2.760 3.670 3.600 3.920
Capex 1 561 529 433 454 643 764 972 938
Capex / Sales 14.48% 13.93% 11.31% 11% 14.3% 15.93% 19.17% 17.78%
Announcement Date 2/20/20 2/18/21 2/17/22 2/9/23 2/14/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Ventas, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
44 USD
Average target price
52.47 USD
Spread / Average Target
+19.26%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Healthcare REITs

1st Jan change Capi.
VENTAS, INC. Stock Ventas, Inc.
-11.72% 17.72B
WELLTOWER INC. Stock Welltower Inc.
+4.62% 55.76B
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
-5.05% 13.23B
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+1.40% 7.68B
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-16.54% 5.39B
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+8.62% 3.28B
SABRA HEALTH CARE REIT, INC. Stock Sabra Health Care REIT, Inc.
-2.31% 3.23B
AEDIFICA SA Stock Aedifica SA
-5.42% 3.06B
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
-8.15% 2.73B
NATIONAL HEALTH INVESTORS, INC. Stock National Health Investors, Inc.
+12.61% 2.73B
Healthcare REITs
  1. Stock Market
  2. Equities
  3. VTR Stock
  4. Financials Ventas, Inc.